|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| New contraceptive implant receives wide acclaim in Nigeria. |
| New African. 1992 Jun;:19. |
| Over 95% of 1286 Nigerian women who participated in a study involving the contraceptive implant, Norplant, think it is |
| an effective and convenient method of contraception. The study was conducted between 1989 and 1991 by the New |
| York-based Association of Voluntary Surgical Contraception (AVSC) in cooperation with five Nigerian university |
| hospitals. Norplant consists of six small plastic rods, about the size of matchsticks. The rods are inserted under |
| the skin of a woman's upper arm. They prevent pregnancy for up to 5 years. Norplant has been approved as a safe |
| and effective method of contraception in 23 countries, including Finland, Kenya, Thailand and the US. Efforts are |
| now under way for the formal approval of Norplant in Nigeria. Over 95% of the women involved in the Nigerian study |
| said they would recommend the method to a friend. A solid 88% of them continued to use the method during the |
| entire length of the study without asking for the implants to be removed. The women were on average 30 years of age |
| and had four living children. Over half of them said they planned to have more children in the future. One of the main |
| reasons the women said they liked Norplant was because of its convenience. During interviews, some said they |
| were worried about forgetting to take oral contraceptives--a worry eliminated by Norplant. According to the AVSC, the |
| women were thoroughly counseled about the possible side effects of Norplant, notably menstrual irregularities. |
| Some of them considered the side effects to be normal, and most were able to cope well with them when they |
| occurred. Over 90% of the women said their husbands knew about, and approved of, their using the method. The five |
| Nigerian hospitals that participated in the study were Lagos University Teaching Hospital, Ogun State Ministry of |
| Health Hospital, University of Calabar Teaching Hospital, University of Maiduguri Teaching Hospital, and the |
| University of Port Harcourt Teaching Hospital. (PubHealth.info Document ID: CONT3T 1575-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "New contraceptive implant receives wide acclaim in |
| Nigeria.", is(are) Landry E. The source of this article is "New African. 1992 Jun;:19.". This article was published in |
| 1992 in English language(s). (PubHealth.info® Document ID: CONT3T 1575-06. All rights reserved with |
| PubHealth.info) PIN: 11575 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |